Related Experiment Video
Updated: Aug 1, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Recurrent pneumothorax at an infant with miliary tuberculosis
M Ayşin Taşar1, Ilknur Bostanci, Sinan Aslan
1Department of Pediatrics, Ankara Education and Research Hospital, Ankara, Turkey.
Insights
Pneumothorax, a rare complication of miliary tuberculosis (TB), can occur months into treatment in infants. This case highlights delayed pneumothorax during anti-TB therapy in a seven-month-old girl.
Area of Science:
- Pediatrics
- Pulmonology
- Infectious Diseases
Background:
- Miliary tuberculosis (TB) is a severe disseminated form of TB.
- Pneumothorax is a known, albeit rare, complication of TB.
- Early recognition and management are crucial for favorable outcomes in pediatric TB.
Observation:
- A seven-month-old infant with miliary TB developed acute respiratory distress and cyanosis.
- Chest radiography revealed pneumothorax in the right lung during anti-TB therapy.
- The infant experienced recurrent pneumothorax in the same hemithorax after initial treatment.
Findings:
- Pneumothorax can manifest later in the course of anti-TB treatment, not just at diagnosis or early stages.
- This case represents the first reported instance of pneumothorax developing during anti-TB therapy in an infant with miliary TB.
- Recurrence of pneumothorax underscores the potential for delayed complications.
Implications:
- Clinicians should maintain a high index of suspicion for delayed pneumothorax in infants with miliary TB undergoing treatment.
- Extended monitoring may be necessary for pediatric patients with miliary TB, even after initial stabilization.
- This case contributes to understanding the diverse and sometimes delayed complications of miliary TB in infants.
Abstract:
A seven-month-old girl with miliary tuberculosis (Tbc) admitted to hospital due to development of acute dyspnoea and cyanosis at the end of third month of anti-Tbc therapy. Pneumothorax was evident at right lung with the chest radiography. A chest tube placed under water seal was applied. The patient healed up and then discharged. One week later, the patient admitted to hospital again, with same complaints due to pneumothorax at the same hemithorax. Same treatment was applied to the patient. Anti-Tbc therapy was stopped at the end of 12th month. Although, pneumothorax is a rare life-threatening complication of miliary Tbc, it's not seen only on admission or soon after beginning of the therapy, but it can be seen several months later during treatment. We want to report this case. That is the first case in which pneumothorax developed during therapy of an infant with miliary Tbc.
More Related Videos
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Related Concept Videos
Pulmonary Cycle: Exhalation
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II
Clinical Manifestations: